Completed OBSERVATIONAL NCT02380391

EValuation of REsidual Platelet REactivity After Acute Coronary Syndrome (ST+/ST-) in HIV (EVERE2ST-HIV)

EValuation of REsidual Platelet REactivity After Acute Coronary Syndrome in HIV-infected Patients. The EVERE2ST-HIV Study.

Sponsor: Groupe Hospitalier Pitie-Salpetriere

Conditions Acute Coronary Syndrome HIV

Updated 10 times since 2017 Last updated: Feb 28, 2015 Started: Dec 31, 2013 Primary completion: Jun 30, 2014 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02380391, this observational or N/A phase trial focuses on Acute Coronary Syndrome and HIV and remains completed. Sponsored by Groupe Hospitalier Pitie-Salpetriere, it has been updated 10 times since 2013, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Groupe Hospitalier Pitie-Salpetriere
Saint Antoine University Hospital

Data source: Saint Antoine University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France